Shire Pays $1.9M, Boosting ADHD Med Antitrust Deal To $3M
Shire has inked a $1.9 million deal with a proposed class of parents and caregivers in antitrust litigation over attention deficit hyperactivity disorder medication Intuniv, rounding out a $3 million settlement...To view the full article, register now.
Already a subscriber? Click here to view full article